Kensey Nash (KNSY) Acquired by Royal DSM for $38.50/Share
Tweet Send to a FriendGet Alerts KNSY Hot Sheet
Price: $38.46 --0%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.6%
Revenue Growth %: +19.4%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.6%
Revenue Growth %: +19.4%
Trade KNSY Now!
Kensey Nash Corporation (Nasdaq: KNSY) agrees to be acquired by Royal DSM (DSM) (NYSE Euronext: DSM KON) for $38.50 per share in cash, or a 33% over yesterday's close.
The tender offer is currently expected to be completed by the end of June 2012. Following the completion of the tender offer, DSM will acquire the remaining outstanding shares of Kensey Nash common stock through a second step merger, subject to customary conditions.
"We are very pleased to have entered into the merger agreement with DSM, as the transaction will deliver significant value to our stockholders. The price to be paid to our stockholders represents a premium of 33% over our closing price on May 2, 2012," said Joe Kaufmann, President and Chief Executive Officer. "When completed, the transaction will also be a great event for our strategic partners, customers and employees. DSM is a global Life Sciences and Materials Sciences company with sales around euro 9 billion and 22,000 employees worldwide. Their presence in biomedical materials markets comes from a unique convergence between their expertise in Life Sciences and Materials Sciences. Our employees will benefit from the growth and expansion that DSM envisions will occur from this combination of capabilities and resources," Mr. Kaufmann added.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The tender offer is currently expected to be completed by the end of June 2012. Following the completion of the tender offer, DSM will acquire the remaining outstanding shares of Kensey Nash common stock through a second step merger, subject to customary conditions.
"We are very pleased to have entered into the merger agreement with DSM, as the transaction will deliver significant value to our stockholders. The price to be paid to our stockholders represents a premium of 33% over our closing price on May 2, 2012," said Joe Kaufmann, President and Chief Executive Officer. "When completed, the transaction will also be a great event for our strategic partners, customers and employees. DSM is a global Life Sciences and Materials Sciences company with sales around euro 9 billion and 22,000 employees worldwide. Their presence in biomedical materials markets comes from a unique convergence between their expertise in Life Sciences and Materials Sciences. Our employees will benefit from the growth and expansion that DSM envisions will occur from this combination of capabilities and resources," Mr. Kaufmann added.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Sprint (S) to Raise Offer for Clearwire (CLWR) - DJ
- Saks (SKS) Won't Comment on Tonight's Takeover 'Rumor'
- Clearwire (CLWR) Approves Higher Sprint (S) Bid of $3.40/Share
Create E-mail Alert Related Categories
Hot M&A, Mergers and Acquisitions
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
